Maryam Lustberg MD MPH FASCO
banner
maryamlustberg.bsky.social
Maryam Lustberg MD MPH FASCO
@maryamlustberg.bsky.social
Breast Oncologist @yalecancer.bsky.social
#bcsm #survonc; she/her/hers #oncsky

https://medicine.yale.edu/profile/maryam-lustberg/
Reposted by Maryam Lustberg MD MPH FASCO
The editors of @ascocancer.bsky.social's #JCOOncologyAdvances recently met at the ASCO HQ to discuss strategy and planning for the year ahead.
@pamelakunzmd.bsky.social serves as editor-in-chief and she
was joined by associate editors, including Yale’s
@maryamlustberg.bsky.social.
October 9, 2025 at 4:22 PM
Reposted by Maryam Lustberg MD MPH FASCO
@maryamlustberg.bsky.social shares insights on #breastcancer prevention, treatment, and new research, in honor of #breastcancerawarenessmonth tonight at 7:30pm on #YaleCancerAnswers.
🎧Listen live on WNPR
🔁Download on Apple Podcasts
💻Watch on YouTube
October 19, 2025 at 8:49 PM
Reposted by Maryam Lustberg MD MPH FASCO
Thank you to everyone that joined us Wednesday night at the
#SaybrookResortandMarina for an evening of networking and
connections around the topic of #womenshealth!
@maryamlustberg.bsky.social
October 24, 2025 at 3:17 PM
Reposted by Maryam Lustberg MD MPH FASCO
We’re hosting a webinar for members on “Centering Voices: Best Practices for Engaging People with Lived Experience in Supportive Care in Cancer”.

Registration is open to all members. To become a member, click here: mascc.org/join-mascc/

#SuppOnc @maryamlustberg.bsky.social @coffeemommy.bsky.social
November 10, 2025 at 4:17 PM
Reposted by Maryam Lustberg MD MPH FASCO
An empowering + emotional day at our Caring for Metastatic Breast Cancer conference on Saturday. 💗 From groundbreaking research to personal stories of strength, we're reminded: no one faces #MBC alone.
#BreastFriendsFund
@maryamlustberg.bsky.social
October 6, 2025 at 12:14 PM
Reposted by Maryam Lustberg MD MPH FASCO
In metastatic #breastcancer, sacituzumab govitecan given after trastuzumab deruxtecan was linked to ⬇️ PFS across all subtypes. Real-world data published in #JNCI show differences in outcomes by type. academic.oup.com/jnci/advance...
@maryamlustberg.bsky.social
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
AbstractBackground. Most patients with metastatic breast cancer (MBC) are eligible for treatment with trastuzumab deruxtecan (T-DXd). No data are available
academic.oup.com
August 19, 2025 at 11:56 AM
Reposted by Maryam Lustberg MD MPH FASCO
A big thank you once again to our dedicated Social Media Ambassadors for 2025:

@maryamlustberg.bsky.social @darcyburbage.bsky.social
@coffeemommy.bsky.social @bogda-koczwara.bsky.social
@stage4kelly.bsky.social

Thank you for your insightful posting across the three days of #MASCC25!
June 28, 2025 at 10:35 PM
Thank you!
June 28, 2025 at 6:58 AM
Reposted by Maryam Lustberg MD MPH FASCO
Congratulations to @maryamlustberg.bsky.social named an inaugural @cancercaremascc.bsky.social Fellow during #mascc25!
In 2025, we welcome and congratulate our inaugural cohort of MASCC Fellows (FMASCC). Fellow status is awarded to individuals who have made a sustained contribution to MASCC and demonstrated a continued high level of excellence in cancer supportive care practice and/or research.

#MASCC25
June 27, 2025 at 2:04 PM
Reposted by Maryam Lustberg MD MPH FASCO
Really appreciated the invite to speak from #MASCC25 and @maryamlustberg.bsky.social What a great conference! Amazing speakers on the #toxicities panel. #supportivecarematters #CanSky #OncoSky #IDSky
"Common and uncommon toxicities: Perspectives and solutions from patient partners"
Excited to hear from @scottcapozza.bsky.social @evaschumacherwulf.bsky.social @doublewhammied.bsky.social & others

And then to share our @advocatecollab.bsky.social research #MASCC25
June 27, 2025 at 8:48 PM
Reposted by Maryam Lustberg MD MPH FASCO
Kudos and gratitude to the organizers, attendees, and fellow faculty members for today's Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment #MASCC25
@maryamlustberg.bsky.social @tingtingzhang.bsky.social @ericroeland.bsky.social @brueraeduardo.bsky.social
June 26, 2025 at 8:29 PM
Reposted by Maryam Lustberg MD MPH FASCO
Grateful for the insights and discussions shared with the stellar panelists and engaged audience at #MASCC25 workshop for cancer treatment toxicities. @maryamlustberg.bsky.social @ericroeland.bsky.social @coffeemommy.bsky.social and Dr Eduardo Bruera with screenshot from @stage4kelly.bsky.social
June 26, 2025 at 8:39 PM
Reposted by Maryam Lustberg MD MPH FASCO
Introducing our #MASCC25 Social Media Ambassadors on Bluesky! Follow them for daily highlights from across our scientific program:

@maryamlustberg.bsky.social @darcyburbage.bsky.social @coffeemommy.bsky.social @bogda-koczwara.bsky.social @stage4kelly.bsky.social
June 18, 2025 at 2:18 PM
Reposted by Maryam Lustberg MD MPH FASCO
Dr. Melissa Taylor presents data demonstrating the positive impact of ReX, a remote digital nurse app, to ⬇️ medication discontinuation and track #PROs at #ASCO25.
meetings.asco.org/abstracts-pr...
@maryamlustberg.bsky.social @oncoalert.bsky.social @yaleschoolofmed.bsky.social
June 1, 2025 at 1:36 PM
Reposted by Maryam Lustberg MD MPH FASCO
@michael-jefford.bsky.social champions an allstar #survonc panel. 20 years from #IOM paper Lost in Transition. So much ground covered, so much yet to go.

@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
@fumikochino.bsky.social
@maryamlustberg.bsky.social
June 1, 2025 at 1:55 PM
Reposted by Maryam Lustberg MD MPH FASCO
Inspirational words on positioning yourself for success by these four women physician leaders! Sharing advice with early career women in oncology. Now we have the tools for success🛠️✨#ASCO2025 @maryamlustberg.bsky.social @drgattimays.bsky.social @yalecancer.bsky.social
June 1, 2025 at 5:36 PM
Reposted by Maryam Lustberg MD MPH FASCO
Join us to discuss patient partnering in managing chronic toxicities of cancer treatment -with increasing burden from newer regimes on patients, doctors, and our healthcare systems. #medsky #palliative #supportivecare #oncosky #cancer #toxicities
1/2 Don’t miss our #MASCC25 workshop “Partnering with Patients in Managing Chronic Toxicities of Cancer and Its Treatment”, chaired by @maryamlustberg.bsky.social & @tingtingzhang.bsky.social

With presentations from @ericroeland.bsky.social @brueraeduardo.bsky.social and @coffeemommy.bsky.social
May 26, 2025 at 5:20 PM
Reposted by Maryam Lustberg MD MPH FASCO
1/2 Don’t miss our #MASCC25 workshop “Partnering with Patients in Managing Chronic Toxicities of Cancer and Its Treatment”, chaired by @maryamlustberg.bsky.social & @tingtingzhang.bsky.social

With presentations from @ericroeland.bsky.social @brueraeduardo.bsky.social and @coffeemommy.bsky.social
May 26, 2025 at 4:07 PM
Reposted by Maryam Lustberg MD MPH FASCO
Thank you @maryamlustberg.bsky.social for sharing updates from @cancercaremascc.bsky.social to the @pallonccop.bsky.social !!
Looking forward to participating/promoting the many great programs and initiatives!
#oncsky #oncologynursing
May 8, 2025 at 10:10 PM
Reposted by Maryam Lustberg MD MPH FASCO
Reposted by Maryam Lustberg MD MPH FASCO
We're heading to Chicago for the @theaacr.bsky.social Annual Meeting #AACR25! Follow along as we share highlights and news throughout the meeting.
yalecancercenter.org/news-article...
@yaleschoolofmed.bsky.social
Yale Cancer Center Research Breakthroughs Unveiled at AACR Annual Meeting
Yale Cancer Center presentations at the AACR Annual Meeting will include oral and poster presentations as well as educational sessions, showcasing cutting-edge
yalecancercenter.org
April 24, 2025 at 7:48 PM
Reposted by Maryam Lustberg MD MPH FASCO
A @yalecancer.bsky.social -led study examined chemotherapy-induced peripheral neuropathy #CIPN from clinical presentation, risk factors, + treatment strategies to impact of CIPN on QOL + patient experience.
apm.amegroups.org/article/view...
@yaleschoolofmed.bsky.social @maryamlustberg.bsky.social
Chronic chemotherapy-induced peripheral neuropathy: living with neuropathy during and after cancer treatments
Chronic chemotherapy-induced peripheral neuropathy: living with neuropathy during and after cancer treatments
apm.amegroups.org
April 24, 2025 at 2:04 PM
Reposted by Maryam Lustberg MD MPH FASCO
Watch the recording from our recent webinar: Innovative Approaches in the Management of Bone Metastasis: Enhancing Patient Outcomes Through Safe Exercise, Skeletal-Related Event (SREs) Prevention, and Biosimilars

vimeo.com/1071779724?s...

#SuppOnc @fatmabenabid.bsky.social
MASCC Webinar: Innovative Approaches in the Management of Bone Metastasis
Innovative Approaches in the Management of Bone Metastasis: Enhancing Patient Outcomes Through Safe Exercise, Skeletal-Related Event (SREs) Prevention, and Biosimilars Learning…
vimeo.com
April 8, 2025 at 1:39 PM